Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #57,451 to #57,500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Sodium-chloride symporter (4 revisions)
  2. Sodium tartrate (4 revisions)
  3. Sodium zirconium cyclosilicate (4 revisions)
  4. Solitary mastocytoma (4 revisions)
  5. Solitary pulmonary nodule CT scan (4 revisions)
  6. Solitary pulmonary nodule pathophysiology (4 revisions)
  7. Solitary pulmonary nodule x ray (4 revisions)
  8. Somatostatin receptor 1 (4 revisions)
  9. Somatostatin receptor 3 (4 revisions)
  10. Somatostatin receptor 4 (4 revisions)
  11. Somatostatin receptor 5 (4 revisions)
  12. Sore mouth infection cost-effectiveness of therapy (4 revisions)
  13. Sore mouth infection future or investigational therapies (4 revisions)
  14. Sore mouth infection laboratory findings (4 revisions)
  15. Sore mouth infection other diagnostic studies (4 revisions)
  16. Sore mouth infection physical examination (4 revisions)
  17. Southern tick-associated rash illness risk factors (4 revisions)
  18. Specific inhalation challenge (4 revisions)
  19. Spectinomycin description (4 revisions)
  20. Spesolimab-sbzo (4 revisions)
  21. Spherocytosis natural history, complications and prognosis (4 revisions)
  22. Spherocytosis pathophysiology (4 revisions)
  23. Spina bifida classification (4 revisions)
  24. Spina bifida electroencephalogram (4 revisions)
  25. Spina bifida laboratory findings (4 revisions)
  26. Spina bifida overview (4 revisions)
  27. Spina bifida surgery (4 revisions)
  28. Spina bifida x ray (4 revisions)
  29. Spinal Muscular atrophy Risk Factor (4 revisions)
  30. Spinal Muscular atrophy overview (4 revisions)
  31. Spinal Muscular atrophy symptom (4 revisions)
  32. Spinal cord injury (patient information) (4 revisions)
  33. Spinal disc herniation (4 revisions)
  34. Spinal manipulation (4 revisions)
  35. Spinal muscular atrophy genetics (4 revisions)
  36. Spinal muscular atrophy risk factor (4 revisions)
  37. Spinal muscular atrophy therapeutics development (4 revisions)
  38. Spinal muscular atrophy treatment (4 revisions)
  39. Spinal stenosis diagnostic study of choice (4 revisions)
  40. Spinal stenosis epidemiology and demographics (4 revisions)
  41. Spinal stenosis natural history, complications and prognosis (4 revisions)
  42. Spinal stenosis risk factors (4 revisions)
  43. Splenic infarction causes (4 revisions)
  44. Splenic marginal zone lymphoma case study one (4 revisions)
  45. Splenic marginal zone lymphoma cost-effectiveness of therapy (4 revisions)
  46. Splenic marginal zone lymphoma future or investigational therapies (4 revisions)
  47. Splenomegaly case study one (4 revisions)
  48. Splenomegaly cost-effectiveness of therapy (4 revisions)
  49. Splenomegaly future or investigational therapies (4 revisions)
  50. Spondyloarthropathy medical therapy (4 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"